INNOVATE • INTERACT • INVEST
Cancer Progress Conference 2022 Panels
Patients Front and Center
How to Catch and Treat Cancer Early
Stage of the Art in Immuno-Oncology: Beyond PDx Inhibitors – or Not So Much
The Latest Potential “Paradigm-Shifters”
ADC “The Next Generation”
Biotechs to Go It Alone - Launch Strategy for Success
How to Value Value: HEOR, HTA, ICER & Other Scary Acronyms for Oncology Developers!
What’s Hot/What’s Not for Startups in the Quasi-Post-Pandemic Oncology World?
Biotech versus Pharma Perspectives - Clinical Development Strategy
Cancer Vaccines Redux: mRNA, Oncolytic Viruses, Or Good Old-Fashioned Peptides - Is It the Target(s), Immunization Platform, Clin Dev Strategy, or All of the Above?
Does RNA Rule the World?
Growing Pains - Navigating the Precipitous Path Towards Commercialization
Tortoises and Hares - De-risking Strategies Towards Multiplexed Candidates
Selling the Cell - Cost-benefit Considerations for Complex Therapeutics
Building on Success - Clinical and Commercial Dynamics in Heme Malignancies and Hematopoietic Transplantation
Tools of the Trade - Strategic Positioning of Emerging Cell Types, Target Discovery Engines, and Gene Engineering Tools
Battle of the Modalities: The Sequel to the Sequel - Revenge of the Nerds
Leading Companies and Institutions that attended Cancer Progress 2021
Good array of opinions and technologies. Well curated
Andrew Allen, MD, PhD, President & CEOGritstone Oncology
As I like to say, Cancer Progress is THE BEST non-academic cancer conference out there. Again proving your staggering insight!
Michael G. King, Jr., Entrepreneur in ResidenceFortress Biotech Inc.
When we hear all the negatives from the experts on cell therapies and COVID—let’s think of Richard Feynman: “Science is the belief in the ignorance of the experts
Mark Simon, Managing DirectorTorreya
“Thank you for the opportunity. I felt privileged to be part of a panel composed of stellar leaders within the Oncology space.”
“I really enjoyed the meeting as usual – great topics and speakers. I look forward to next year’s meeting!”